Study design and intervention
chronic kidney disease
This study is a controlled, double-blind 6-month randomized clinical trial. From March 2020 to September 2021, 85 patients who had undergone transplantation for chronic kidney disease in Abu Ali Sina Organ Transplant in Shiraz, Iran, were screened. Forty-two patients who met the inclusion criteria after transplant were randomly allocated with a 1:1 allocation ratio parallelly using random block sizes by Stata statistical software into the intervention and control groups (Fig. CONSORT flow diagram. Participants' flow throughout the studyThere were no significant changes in the trial methods or outcomes after the start of the experiment. We used the Consolidated Standards for Reporting of Trials (CONSORT) statement in order to improve the quality of this randomized controlled trial (RCT) report [